Article

ENO1 as a biomarker of breast cancer progression and metastasis – a bioinformatic approach

2023-11-01

Abstract excerpt

<h4>Background</h4> Metabolic reprogramming is one of the hallmarks of cancer cells and many key metabolic enzymes are dysregulated. In breast cancer (BC), the commonest malignancy of women, several metabolic enzymes are overexpressed and/or overactivated. One of these is Enolase 1 (ENO1) an enzyme that catalyses glycolysis but is also involved in the regulation of multiple signalling pathways. ENO1 overexpression...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d6d16cff-a3b2-5f93-aab0-90aef82b8bb5
DOI: 10.1101/2023.11.01.23297919

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

ENO1 as a biomarker of breast cancer progression and metastasis – a bioinformatic approachDOI 10.1101/2023.11.01.23297919Read

A Bioinformatic Characterisation of the Glyolytic Enzyme ENO1 as a Biomarker of Breast Cancer ProgressionSemantic proximity Read

The role of CPT1A as a biomarker of breast cancer progression: a bioinformatic approachSemantic proximity Read

The Role of CPT1A as a Biomarker of Breast Cancer Progression – A Bioinformatic AnalysisSemantic proximity Read

Multiomics reveals the role of ENO1 in bladder cancer and constructs an epithelial-related prognostic model to predict prognosis and efficacySemantic proximity Read

Beyond ENO1, emerging roles and targeting strategies of other enolases in cancersSemantic proximity Read

Integrative Analysis of the Expression Levels and Prognostic Values for NEK Family Members in Breast CancerSemantic proximity Read

Elevated EXO1 expression is associated with breast carcinogenesis and poor prognosisSemantic proximity Read

Network analysis allows to unravel breast cancer molecular features and to identify novel targetsSemantic proximity Read

Enolase-1 serves as a biomarker of diagnosis and prognosis in hepatocellular carcinoma patientsSemantic proximity Read

Prognostic significance of KN motif and ankyrin repeat domains 1 (KANK1) in invasive breast cancerSemantic proximity Read

Epigenetic markers of tumor progression in estrogen receptor–positive breast cancer patients with high nodal involvementSemantic proximity Read

ERO1α as a potential drug target for breast cancer: a systematic review of current evidenceSemantic proximity Read